Jubilant Therapeutics

Jubilant Therapeutics develops selective small molecule modulators targeting genetically-defined cancers and autoimmune disorders, focusing on specific genetic mutations and drug resistance mechanisms. The company aims to meet unmet medical needs by advancing its clinical-stage programs through strategic partnerships and fast-tracking them from discovery to pivotal studies.

Traction 5/10

Bedminster, United States · HQ

Founded 2019123K+ followers

Biotechnology

Updated 7 months ago

Funding

Funding rounds are not available yet.

Founders

1 founder

Syed Kazmi

President and CEO

Product

Features

Jubilant Therapeutics develops selective small molecule modulators targeting genetically-defined cancers and autoimmune disorders, focusing on specific genetic mutations and drug resistance mechanisms. The company aims to meet unmet medical needs by advancing its clinical-stage programs through strategic partnerships and fast-tracking them from discovery to pivotal studies.